✦ LIBER ✦

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer

✍ Scribed by Wu, Jenn-Yu; Yu, Chong-Jen; Yang, Chih-Hsin; Wu, Shang-Gin; Chiu, Yueh-Hsia; Gow, Chien-Hung; Chang, Yeun-Chung; Hsu, Ya-Chieh; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr

Book ID: 125515658
Publisher: American Thoracic Society
Year: 2008
Tongue: English
Weight: 138 KB
Volume: 178
Category: Article
ISSN: 1073-449X
DOI: 10.1164/rccm.200803-389OC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib as first-line, compassionate u

Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer

✍ Argiris, Athanassios; Mittal, Namrata 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Second-line treatments after first-line

Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer

✍ Jenn-Yu Wu; Jin-Yuan Shih; Chih-Hsin Yang; Kuan-Yu Chen; Chao-Chi Ho; Chong-Jen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 236 KB

## Abstract Gefitinib is effective as first‐line therapy for advanced nonsmall cell lung cancer (NSCLC). However, after failure of gefitinib, it is unknown whether any second‐line regimens could lead to better outcomes. To study the influence of different second‐line antitumor regimens on the outco

Gefitinib as First-line Therapy for Adva

Gefitinib as First-line Therapy for Advanced or Metastatic Non-small Cell Lung Cancer Patients in Southern Taiwan

✍ Cheng-Ta Yang; Jen-Yu Hung; Chun-Liang Lai; Hsin-Chia Hung; Yung-Fa Lai; Meng-Ch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 312 KB

P-599 Gefitinib(Iressa) as first-line th

P-599 Gefitinib(Iressa) as first-line therapy in advanced non-small lung cancer

✍ Zimmermann, M.; Luthi, E.; Zouhair, A.; Bauer, J.; Leyvraz, S.; Stupp, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Advanced Non–Small-Cell Lung Cancer Patients

✍ Yong-mei Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Influence of first-line chemotherapy and

Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer

✍ Wu, Jenn-Yu; Yu, Chong-Jen; Shih, Jin-Yuan; Yang, Chih-Hsin; Yang, Pan-Chyr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB